These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35496795)

  • 1. Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a.
    Ling X; Chang L; Chen H; Liu T
    STAR Protoc; 2022 Jun; 3(2):101321. PubMed ID: 35496795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
    Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
    Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy.
    Ding R; Chao CC; Gao Q
    Methods Cell Biol; 2022; 167():1-14. PubMed ID: 35152989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art.
    Ciurkot K; Vonk B; Gorochowski TE; Roubos JA; Verwaal R
    J Vis Exp; 2019 May; (147):. PubMed ID: 31205318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells.
    Mohr M; Damas N; Gudmand-Høyer J; Zeeberg K; Jedrzejczyk D; Vlassis A; Morera-Gómez M; Pereira-Schoning S; Puš U; Oliver-Almirall A; Lyholm Jensen T; Baumgartner R; Tate Weinert B; Gill RT; Warnecke T
    ACS Synth Biol; 2023 Feb; 12(2):375-389. PubMed ID: 36750230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas.
    Nievergelt AP; Diener DR; Bogdanova A; Brown T; Pigino G
    STAR Protoc; 2024 Mar; 5(1):102774. PubMed ID: 38096061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas12a ribonucleoprotein-mediated gene editing in the plant pathogenic fungus
    Huang J; Cook DE
    STAR Protoc; 2022 Mar; 3(1):101072. PubMed ID: 35005648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12a.
    Li W; Chan C; Zeng C; Turk R; Behlke MA; Cheng X; Dong Y
    Bioconjug Chem; 2020 Mar; 31(3):542-546. PubMed ID: 32119776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Off-Target Effect of CRISPR-Cas12a System toward Insertions and Deletions between Target DNA and crRNA Sequences.
    Zhang W; Shi R; Dong K; Hu H; Shu W; Mu Y; Yan B; Li L; Xiao X; Wang H
    Anal Chem; 2022 Jun; 94(24):8596-8604. PubMed ID: 35670376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference.
    Zhao Y; Boeke JD
    Nucleic Acids Res; 2020 Jun; 48(10):5788-5798. PubMed ID: 32374858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas12a-Mediated Genome Editing in
    Hao X; Mu T; Sharshar MM; Jia Y; Zhong W; Chen Z; Wen Q; Yang M; Wang C; Xing J
    ACS Synth Biol; 2023 Apr; 12(4):1204-1215. PubMed ID: 37017652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy.
    Li C; Mei H; Hu Y
    Brief Funct Genomics; 2020 May; 19(3):175-182. PubMed ID: 31950135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas12a assisted precise genome editing of Mycolicibacterium neoaurum.
    Liu K; Gao Y; Li ZH; Liu M; Wang FQ; Wei DZ
    N Biotechnol; 2022 Jan; 66():61-69. PubMed ID: 34653700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
    Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
    STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.